Diversification of a Novel α‐Galactosyl Ceramide Hotspot Boosts the Adjuvant Properties in Parenteral and Mucosal Vaccines - Angewandte Chemie International Edition - Wiley Online Library https://t.co/fvEOBS54oS
As the UN discuss Ukraine, which is important to global security, a much bigger threat is increasing in the world that is the interaction between climate change and epidemics - a good and sad example is how two extreme events in Pakistan and Malawi fuelled the world worst cholera epidemic -https://t.co/BgRNbFkTln Libya may be at danger of a new Cholera epidemic and we urge the world to act until is late.
Merging Solid-Phase Peptide Synthesis and Automated Glycan Assembly to Prepare Lipid-Peptide-Glycan Chimeras (Peter H. Seeberger and co-workers) @ManuelG_Ricardo @peterseeberger@MpiciPotsdam https://t.co/XLXbBbOfeI
Soberana 02 and Soberana Plus protein-based COVID-19 vaccines show promising immunogenicity, efficacy and safety profiles in a multicenter randomized double-blind, placebo-controlled, phase 3 trial in Iran. @Pasteur_Iran@FinlayInstituto#Pastocovac https://t.co/EV0CO2Zt7X
Visiting the University of Bielfeld @unibielefeld, and sharing ideas with Norbert Sewald and his amazing group of students. More on peptide-drug conjugates in the #magicbulletreloaded symposium.
Most people from the so-called 'Global South' cannot travel to Europe because European governments believe that COVID-19 vaccines developed in our countries are not good enough. This is technological racism, it is a continuation of the same racism by new means.
A nice and complete interactive overview on the five different SARS-CoV-2 Cuban Public vaccines (and candidates) @cubadebatecu
Immense work and achievements for @BioCubaFarma@FinlayInstituto@CIGBCuba@centro_cim
Thanks for all that!
https://t.co/vVIFlr3uE3
Ya está disponible el Episodio 2 de nuestro podcast 🎙 Reacción en Cadena titulado "Vacunas y universidad - Entrevista a Daniel García"
Encuéntranos en tus plataformas de podcast favoritas cada 15 días
Produce: @NexosMultimedia
¿Cómo escucharnos? En el siguiente tuit 👇
Happy to share this article on the development of a new COVID-19 vaccine candidate, soon to be approved for emergency use in Cuba. It will be a powerful asset in the fight against Omicron in the upcoming months.
https://t.co/VvtnwLG0ZD
Indeed it was a clever bet, we always said it, we need our own vaccines. #Soberana is a tremendous success.
Cuba’s bet on home-grown COVID vaccines is paying off https://t.co/7wKNAtkcdQ
26 million doses of Cuban SARS-CoV-2 protein-based vaccines administred are not enough to be mentioned @Nature by @ElieDolgin. With different peer-reviewed articles accepted, others on medRxiv and with already different citations on key reviews around... Please...
Confirman los resultados de Ensayo Clínico Fase III desarrollado por el Instituto Pasteur de Irán eficacia de vacunas #SOBERANA02 y #SOBERANAPlus frente a la cepa Delta. #VacunasCubanasCovid19